These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 1436233
1. Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells. Shiryaeva OA, Semenova NA, Sibeldina LA, Goncharova SA, Konovalova NP. Neoplasma; 1992; 39(4):229-32. PubMed ID: 1436233 [Abstract] [Full Text] [Related]
6. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia. Tsuruo T, Oh-Hara T, Sudo Y, Naito M. Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647 [Abstract] [Full Text] [Related]
9. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy. Yanovich S, Taub RN. Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858 [Abstract] [Full Text] [Related]
10. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells. Chou TH, Kessel D. Biochem Pharmacol; 1981 Nov 15; 30(22):3134-6. PubMed ID: 6950722 [No Abstract] [Full Text] [Related]
14. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. Ramu A, Fuks Z, Gatt S, Glaubiger D. Cancer Res; 1984 Jan 15; 44(1):144-8. PubMed ID: 6690032 [Abstract] [Full Text] [Related]
15. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists. Klohs WD, Steinkampf RW, Havlick MJ, Jackson RC. Cancer Res; 1986 Sep 15; 46(9):4352-6. PubMed ID: 3460695 [Abstract] [Full Text] [Related]